These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15904905)

  • 1. Significance and role of early-lesions in experimental colorectal carcinogenesis.
    Mori H; Hata K; Yamada Y; Kuno T; Hara A
    Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
    Mori H; Yamada Y; Kuno T; Hirose Y
    Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
    Yamada Y; Mori H
    Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
    Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
    Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis.
    Femia AP; Dolara P; Giannini A; Salvadori M; Biggeri A; Caderni G
    Cancer Res; 2007 Jan; 67(2):445-9. PubMed ID: 17234750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
    Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
    Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mucin depleted foci in the human colon.
    Femia AP; Giannini A; Fazi M; Tarquini E; Salvadori M; Roncucci L; Tonelli F; Dolara P; Caderni G
    Cancer Prev Res (Phila); 2008 Dec; 1(7):562-7. PubMed ID: 19139006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis.
    Hirose Y; Kuno T; Yamada Y; Sakata K; Katayama M; Yoshida K; Qiao Z; Hata K; Yoshimi N; Mori H
    Carcinogenesis; 2003 Jan; 24(1):107-11. PubMed ID: 12538355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
    Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
    Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61: 1874-1878, 2001.
    Pretlow TP; Bird RP
    Cancer Res; 2001 Oct; 61(20):7699-701. PubMed ID: 11606415
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats.
    Femia AP; Bendinelli B; Giannini A; Salvadori M; Pinzani P; Dolara P; Caderni G
    Int J Cancer; 2005 Aug; 116(1):9-15. PubMed ID: 15751047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early events in human colorectal carcinogenesis. Aberrant crypts and microadenoma.
    Roncucci L
    Ital J Gastroenterol; 1992; 24(9):498-501. PubMed ID: 1489980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride.
    Yoshimi N; Morioka T; Kinjo T; Inamine M; Kaneshiro T; Shimizu T; Suzui M; Yamada Y; Mori H
    Cancer Sci; 2004 Oct; 95(10):792-7. PubMed ID: 15504245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new medium-term rat colorectal bioassay applying neoplastic lesions as end points for detection of carcinogenesis modifiers effects with weak or controversial modifiers.
    Cho YM; Imai T; Ota Y; Hasumura M; Takami S; Hirose M; Nishikawa A
    Toxicol Pathol; 2008 Apr; 36(3):459-64. PubMed ID: 18349425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.
    Tanaka T; Suzuki R; Kohno H; Sugie S; Takahashi M; Wakabayashi K
    Carcinogenesis; 2005 Jan; 26(1):229-38. PubMed ID: 15459021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.